More on EDIT
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $2.72 |
|
|||
| Open | $2.73 | ||||
| 52 Wk High | $43.99 | ||||
| 52 Wk Low | $12.43 | ||||
| Day High | $2.83 | ||||
| Day Low | $2.68 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 17,031,033 | ||||
- Editas Medicine grants stock options to new chief medical officer
- Editas Medicine Reports Inducement Grants to New Chief Medical Officer
- Editas Medicine names Dan Ory as chief medical officer
- Editas Medicine Appoints Dan Ory, M.D., as Chief Medical Officer
- Editas Medicine to Participate in Upcoming Investor Conferences
- Ladenburg Thalmann Starts Editas Medicine (EDIT) at Buy
- Form SCHEDULE 13G Editas Medicine, Inc. Filed by: ADAR1 Capital Management, LLC
- Form 4 Editas Medicine, Inc. For: Aug 06 Filed by: Ellinor Patrick Thomas II
- Form 3 Editas Medicine, Inc. For: Aug 06 Filed by: Ellinor Patrick Thomas II
- Editas Medicine (EDIT) Tops Q2 EPS by 12c
Entities mentioned with EDIT
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- JPMorgan | View Related Stories »
- Morgan Stanley | View Related Stories »
- 13G | View Related Stories »
- ARK | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Show More...
